» Articles » PMID: 36159243

A Retrospective Analysis of Respiratory Virus Transmission Before and During the COVID-19 Pandemic in Pune the Western Region of India

Abstract

Background: SARS-CoV-2 was first reported in China in December 2019 and quickly spread across the world. Non-pharmaceutical interventions (NPIs) are the key to control the transmission of respiratory viruses. To stop the spread, NPI is widely recommended and is still followed by most countries.

Methods: At the National Influenza Center of the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), the surveillance of severe acute respiratory illness and acute respiratory illness cases for influenza and other respiratory viruses is in place. In this study, we analyzed surveillance data on respiratory viruses and/or SARS-CoV-2 testing from January 2017 to December 2021. Multiplex real-time PCR was used to detect the respiratory viruses.

Results: Our findings indicate that during the pandemic, the positivity for influenza A and B, metapneumovirus, parainfluenza virus, respiratory syncytial virus, and human coronavirus declined significantly.

Conclusion: The annual distinct seasonal outbreaks of influenza, RSV, and other respiratory viruses as observed during the pre-COVID-19 period were not observed during the COVID-19 pandemic in years 2020 and 21. Social distancing, lock-downs, and non-pharmaceutical interventions may play an important role in the reduction of respiratory viruses. Understanding the seasonal respiratory virus decline could help public health experts prepare for future respiratory virus pandemics.

Citing Articles

Distinct seasonality and increased respiratory failure in RSV patients < 2 years of age after emergence of SARS-CoV-2: data from the multicentric, prospective PAPI study.

Bahre J, Lange M, Salaschek P, Twardella D, Arens S, Eberhard F Eur J Pediatr. 2025; 184(4):246.

PMID: 40080186 PMC: 11906531. DOI: 10.1007/s00431-025-06057-0.


Changes in Respiratory Viruses' Activity in Children During the COVID-19 Pandemic: A Systematic Review.

Maglione M, Tipo V, Barbieri E, Ragucci R, Ciccarelli A, Esposito C J Clin Med. 2025; 14(4).

PMID: 40004915 PMC: 11856189. DOI: 10.3390/jcm14041387.


The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review.

Chuang Y, Lin K, Wang L, Yeh T, Liu P Infect Drug Resist. 2023; 16:661-675.

PMID: 36743336 PMC: 9897071. DOI: 10.2147/IDR.S396434.


The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic.

Alkharsah K Medicina (Kaunas). 2022; 58(11).

PMID: 36363580 PMC: 9693047. DOI: 10.3390/medicina58111623.

References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C . Laboratory-Confirmed Respiratory Infections as Predictors of Hospital Admission for Myocardial Infarction and Stroke: Time-Series Analysis of English Data for 2004-2015. Clin Infect Dis. 2018; 67(1):8-17. PMC: 6005111. DOI: 10.1093/cid/cix1144. View

3.
Potdar V, Choudhary M, Bhardwaj S, Ghuge R, Sugunan A, Gurav Y . Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India. Indian J Med Res. 2020; 151(5):486-489. PMC: 7530434. DOI: 10.4103/ijmr.IJMR_638_20. View

4.
Dai L, Gao G . Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2020; 21(2):73-82. PMC: 7747004. DOI: 10.1038/s41577-020-00480-0. View

5.
Fendrick A, Monto A, Nightengale B, Sarnes M . The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003; 163(4):487-94. DOI: 10.1001/archinte.163.4.487. View